Lupartumab
Lupartumab (BAY 1112623) is an anti-LYPD3 (C4.4A) monoclonal antibody that can be used for the synthesis of antibody-drug conjugate BAY 1129980[1].
Product Specifications
CAS Number
[1640971-88-5]
Product Name Alternative
BAY 1112623
UNSPSC
12352203
Target
ADC Antibody
Type
Inhibitory Antibodies
Related Pathways
Antibody-drug Conjugate/ADC Related
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/lupartumab.html
Purity
99.52
Solubility
H2O
Smiles
[Lupartumab]
Molecular Weight
(145.5 kDa)
References & Citations
[1]Willuda J, et al. Preclinical Antitumor Efficacy of BAY 1129980-a Novel Auristatin-Based Anti-C4.4A (LYPD3) Antibody-Drug Conjugate for the Treatment of Non-Small Cell Lung Cancer. Mol Cancer Ther. 2017 May;16 (5) :893-904.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
124145-ML490 100 µL
C5AR1 (C5a Anaphylatoxin Chemotactic Receptor, C5a-R, C5aR, CD88, C5AR, C5R1) (MaxLight 490)
Ask
View Details 
MBS9322251-03 5x 96 Well
Human Uncharacterized protein C10orf82, C10orf82 ELISA Kit
Ask
View Details